XRAY, US24906P1093

Leerink cuts target for Dentsply Sirona stock to USD 10.00

Published on 10/18/2026 at 13:05 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Q2 revenue fell 4.10 percent year over year to USD 898.0 million. Dentsply Sirona stock gets its next earnings test on November 5.

Numbers shaping the setup

  • Leerink cut its Dentsply Sirona target to USD 10.00 on October 14, 2026.
  • Second-quarter revenue reached USD 898.0 million on August 6, 2026.
  • Dentsply Sirona is scheduled to report third-quarter results on November 5, 2026.
XRAY, US24906P1093, Illustration mit AI erstellt.

Dentsply Sirona (ISIN US24906P1093) faces a lower analyst valuation after Markets Insider reported on October 14, 2026, that Leerink cut its price target to USD 10.00 from USD 14.00 and kept a Market Perform rating. The revision places the turnaround plan and the next quarterly report at the center of the stock story.

Three events reset expectations

The company reported second-quarter 2026 revenue of USD 898.0 million on August 6, 2026, down 4.10 percent year over year. Adjusted earnings per share were USD 0.52, while operating cash flow reached USD 99.0 million versus USD 48.0 million in the prior-year quarter, according to the Yahoo Finance transcript.

On October 6, 2026, Dentsply Sirona announced an expanded Midwest Dental relationship that will add its technology portfolio to the distributor's U.S. offering from November 1, 2026. The agreement was the company's seventh North American dealer partnership enhancement of 2026, according to the Dentsply Sirona release.

What does the target cut mean?

The lower USD 10.00 target follows the Q2 sales decline and the company's warning that third-quarter revenue would decline sequentially because of normal seasonality. Management maintained 2026 net sales guidance of USD 3.5 billion to USD 3.6 billion and adjusted earnings-per-share guidance of USD 1.40 to USD 1.50, excluding tariff-refund benefits, according to the Yahoo Finance transcript.

Dates that could move the story

Midwest Dental is scheduled to begin offering the technology portfolio on November 1, 2026. Dentsply Sirona is estimated to report third-quarter 2026 results on November 5, 2026, after the market closes, with a conference call scheduled for 8:30 a.m. ET, according to MarketBeat.

Turnaround metrics remain central

Dentsply Sirona's market capitalization was USD 1.7 billion as of October 16, 2026. The next report will test whether dealer expansion and investment in sales, education and research can offset the 4.10 percent second-quarter revenue decline.

The further course of trading is shown by the continuously updated real-time quote of XRAY stock.

Dentsply Sirona stock facts

  • Company: DENTSPLY SIRONA Inc.
  • ISIN: US24906P1093
  • Ticker: XRAY
  • Primary exchange: Nasdaq
  • Market capitalization: USD 1.7 billion (as of October 16, 2026)
  • Sector / Industry: Healthcare / Medical instruments and supplies
  • Index membership: S&P 500

Market context: Market report S&P 500.

More news and analyses on XRAY stock

Disclaimer...
en | US24906P1093 | XRAY | boerse | 70353292 | bgmi